New Preoperative Regimen Gets a Win in Pancreatic Cancer

(MedPage Today) — CHICAGO — A neoadjuvant chemotherapy regimen of cisplatin (Platinol), nab-paclitaxel (Abraxane), capecitabine (Xeloda), and gemcitabine (PAXG) topped a standard option in a randomized trial of resectable or borderline resectable…